Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 107

1.

Editorial.

Topal G, Clària J, Norel X, Steinhilber D, Jakobsson PJ, Doğan SU, Bannenberg G.

Prostaglandins Other Lipid Mediat. 2015 Sep;121(Pt A):1-3. doi: 10.1016/j.prostaglandins.2015.11.001. No abstract available.

PMID:
26686915
2.

Autoantibodies to citrullinated proteins induce joint pain independent of inflammation via a chemokine-dependent mechanism.

Wigerblad G, Bas DB, Fernades-Cerqueira C, Krishnamurthy A, Nandakumar KS, Rogoz K, Kato J, Sandor K, Su J, Jimenez-Andrade JM, Finn A, Bersellini Farinotti A, Amara K, Lundberg K, Holmdahl R, Jakobsson PJ, Malmström V, Catrina AI, Klareskog L, Svensson CI.

Ann Rheum Dis. 2015 Nov 27. pii: annrheumdis-2015-208094. doi: 10.1136/annrheumdis-2015-208094. [Epub ahead of print]

3.

Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss.

Krishnamurthy A, Joshua V, Haj Hensvold A, Jin T, Sun M, Vivar N, Ytterberg AJ, Engström M, Fernandes-Cerqueira C, Amara K, Magnusson M, Wigerblad G, Kato J, Jiménez-Andrade JM, Tyson K, Rapecki S, Lundberg K, Catrina SB, Jakobsson PJ, Svensson C, Malmström V, Klareskog L, Wähämaa H, Catrina AI.

Ann Rheum Dis. 2015 Nov 26. pii: annrheumdis-2015-208093. doi: 10.1136/annrheumdis-2015-208093. [Epub ahead of print]

4.

Expression of Prostaglandin E2 Enzymes in the Synovium of Arthralgia Patients at Risk of Developing Rheumatoid Arthritis and in Early Arthritis Patients.

de Hair MJ, Leclerc P, Newsum EC, Maijer KI, van de Sande MG, Ramwadhdoebe TH, van Schaardenburg D, van Baarsen LG, Korotkova M, Gerlag DM, Tak PP, Jakobsson PJ.

PLoS One. 2015 Jul 30;10(7):e0133669. doi: 10.1371/journal.pone.0133669. eCollection 2015.

5.

Inhibition of microsomal prostaglandin E synthase-1 as targeted therapy in cancer treatment.

Larsson K, Jakobsson PJ.

Prostaglandins Other Lipid Mediat. 2015 Jul;120:161-5. doi: 10.1016/j.prostaglandins.2015.06.002. Epub 2015 Jun 20.

PMID:
26100239
6.

COX/mPGES-1/PGE2 pathway depicts an inflammatory-dependent high-risk neuroblastoma subset.

Larsson K, Kock A, Idborg H, Arsenian Henriksson M, Martinsson T, Johnsen JI, Korotkova M, Kogner P, Jakobsson PJ.

Proc Natl Acad Sci U S A. 2015 Jun 30;112(26):8070-5. doi: 10.1073/pnas.1424355112. Epub 2015 Jun 15.

7.

Targeting of anti-citrullinated protein/peptide antibodies in rheumatoid arthritis using peptides mimicking endogenously citrullinated fibrinogen antigens.

Fernandes-Cerqueira C, Ossipova E, Gunasekera S, Hansson M, Mathsson L, Catrina AI, Sommarin Y, Klareskog L, Lundberg K, Rönnelid J, Göransson U, Jakobsson PJ.

Arthritis Res Ther. 2015 Jun 10;17:155. doi: 10.1186/s13075-015-0666-6.

8.

Impaired vagus-mediated immunosuppression in microsomal prostaglandin E synthase-1 deficient mice.

Le Maître E, Revathikumar P, Idborg H, Raouf J, Korotkova M, Jakobsson PJ, Lampa J.

Prostaglandins Other Lipid Mediat. 2015 Sep;121(Pt B):155-62. doi: 10.1016/j.prostaglandins.2015.05.006. Epub 2015 May 19.

PMID:
26001880
9.

MPGES-1-derived PGE2 suppresses CD80 expression on tumor-associated phagocytes to inhibit anti-tumor immune responses in breast cancer.

Olesch C, Sha W, Angioni C, Sha LK, Açaf E, Patrignani P, Jakobsson PJ, Radeke HH, Grösch S, Geisslinger G, von Knethen A, Weigert A, Brüne B.

Oncotarget. 2015 Apr 30;6(12):10284-96.

10.

IgG antibodies to cyclic citrullinated peptides exhibit profiles specific in terms of IgG subclasses, Fc-glycans and a fab-Peptide sequence.

Lundström SL, Fernandes-Cerqueira C, Ytterberg AJ, Ossipova E, Hensvold AH, Jakobsson PJ, Malmström V, Catrina AI, Klareskog L, Lundberg K, Zubarev RA.

PLoS One. 2014 Nov 26;9(11):e113924. doi: 10.1371/journal.pone.0113924. eCollection 2014.

11.

Evaluation of urinary prostaglandin E2 metabolite as a biomarker in infants with fever due to viral infection.

Idborg H, Pawelzik SC, Perez-Manso M, Björk L, Hamrin J, Herlenius E, Jakobsson PJ.

Prostaglandins Leukot Essent Fatty Acids. 2014 Dec;91(6):269-75. doi: 10.1016/j.plefa.2014.09.006. Epub 2014 Sep 28.

PMID:
25305792
12.

Affinity purified anti-citrullinated protein/peptide antibodies target antigens expressed in the rheumatoid joint.

Ossipova E, Cerqueira CF, Reed E, Kharlamova N, Israelsson L, Holmdahl R, Nandakumar KS, Engström M, Harre U, Schett G, Catrina AI, Malmström V, Sommarin Y, Klareskog L, Jakobsson PJ, Lundberg K.

Arthritis Res Ther. 2014 Aug 12;16(4):R167. doi: 10.1186/ar4683.

13.

Shared immunological targets in the lungs and joints of patients with rheumatoid arthritis: identification and validation.

Ytterberg AJ, Joshua V, Reynisdottir G, Tarasova NK, Rutishauser D, Ossipova E, Haj Hensvold A, Eklund A, Sköld CM, Grunewald J, Malmström V, Jakobsson PJ, Rönnelid J, Padyukov L, Zubarev RA, Klareskog L, Catrina AI.

Ann Rheum Dis. 2015 Sep;74(9):1772-7. doi: 10.1136/annrheumdis-2013-204912. Epub 2014 May 9.

PMID:
24817415
14.

Persisting eicosanoid pathways in rheumatic diseases.

Korotkova M, Jakobsson PJ.

Nat Rev Rheumatol. 2014 Apr;10(4):229-41. doi: 10.1038/nrrheum.2014.1. Epub 2014 Feb 11. Review.

PMID:
24514915
15.

Differentially expressed proteins in malignant and benign adrenocortical tumors.

Kjellin H, Johansson H, Höög A, Lehtiö J, Jakobsson PJ, Kjellman M.

PLoS One. 2014 Feb 3;9(2):e87951. doi: 10.1371/journal.pone.0087951. eCollection 2014.

16.

Environmental and genetic factors in the development of anticitrullinated protein antibodies (ACPAs) and ACPA-positive rheumatoid arthritis: an epidemiological investigation in twins.

Hensvold AH, Magnusson PK, Joshua V, Hansson M, Israelsson L, Ferreira R, Jakobsson PJ, Holmdahl R, Hammarström L, Malmström V, Askling J, Klareskog L, Catrina AI.

Ann Rheum Dis. 2015 Feb;74(2):375-80. doi: 10.1136/annrheumdis-2013-203947. Epub 2013 Nov 25.

PMID:
24276366
17.

Neutralization of anticitrullinated protein antibodies in rheumatoid arthritis - a way to go?

Cerqueira CF, Klareskog L, Jakobsson PJ.

Basic Clin Pharmacol Toxicol. 2014 Jan;114(1):13-7. doi: 10.1111/bcpt.12157. Epub 2013 Nov 11. Review.

18.

Characterization of microsomal prostaglandin E synthase 1 inhibitors.

Korotkova M, Jakobsson PJ.

Basic Clin Pharmacol Toxicol. 2014 Jan;114(1):64-9. doi: 10.1111/bcpt.12162. Epub 2013 Nov 11. Review.

19.

Characterization of a human and murine mPGES-1 inhibitor and comparison to mPGES-1 genetic deletion in mouse models of inflammation.

Leclerc P, Idborg H, Spahiu L, Larsson C, Nekhotiaeva N, Wannberg J, Stenberg P, Korotkova M, Jakobsson PJ.

Prostaglandins Other Lipid Mediat. 2013 Dec;107:26-34. doi: 10.1016/j.prostaglandins.2013.09.001. Epub 2013 Sep 14.

PMID:
24045148
20.

Effects of mPGES-1 deletion on eicosanoid and fatty acid profiles in mice.

Idborg H, Olsson P, Leclerc P, Raouf J, Jakobsson PJ, Korotkova M.

Prostaglandins Other Lipid Mediat. 2013 Dec;107:18-25. doi: 10.1016/j.prostaglandins.2013.07.004. Epub 2013 Aug 2.

PMID:
23916744
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk